Attached files

file filename
EX-21 - EXHIBIT 21 - CALMARE THERAPEUTICS Inccttc10k2011a3x21.htm
EX-32 - EXHIBIT 32.1 - CALMARE THERAPEUTICS Inccttc10k2011a3x321.htm
EX-31 - EXHIBIT 31.1 - CALMARE THERAPEUTICS Inccttc10k2011a3x311.htm
EX-31 - EXHIBIT 31.2 - CALMARE THERAPEUTICS Inccttc10k2011a3x312.htm
10-K - COMPETITIVE TECHNOLOGIES, INC. ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2011 - CALMARE THERAPEUTICS Inccttc10k2011.pdf
EXCEL - IDEA: XBRL DOCUMENT - CALMARE THERAPEUTICS IncFinancial_Report.xls
10-K - COMPETITIVE TECHNOLOGIES, INC. ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2011 - CALMARE THERAPEUTICS Inccttc10k2011.htm

Exhibit 32.2


CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. 1350)



In connection with the Annual Report of Competitive Technologies, Inc. (the "Company") on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Johnnie D. Johnson, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), that to my knowledge:


1.

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Johnnie D. Johnson

Johnnie D. Johnson

Chief Financial Officer

(Principal Financial and Accounting Officer)

April 16, 2012